BlackRock Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

BlackRock Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$919K	Buy	190,295 +130,731	+219%	+$3.88M	﹤0.01%	1902
2016 Q3	$2.75M	Buy	59,564 +6,109	+11%	+$345K	﹤0.01%	1349
2016 Q2	$2.73M	Buy	53,455 +2,451	+5%	+$122K	﹤0.01%	1324
2016 Q1	$2.16M	Buy	51,004 +22,760	+81%	+$1.16M	﹤0.01%	1387
2015 Q4	$2.22M	Buy	28,244 +6,984	+33%	+$404K	﹤0.01%	1370
2015 Q3	$861K	Sell	21,260 -44,165	-68%	-$2.34M	﹤0.01%	1796
2015 Q2	$3.41M	Buy	65,425 +52,962	+425%	+$2.63M	﹤0.01%	1096
2015 Q1	$580K	Sell	12,463 -27,140	-69%	-$1.41M	﹤0.01%	1973
2014 Q4	$1.78M	Buy	39,603 +32,781	+481%	+$1.38M	﹤0.01%	1240
2014 Q3	$266K	Buy	6,822 +959	+16%	+$37.6K	﹤0.01%	2425
2014 Q2	$248K	Sell	5,863 -48,314	-89%	-$1.77M	﹤0.01%	2503
2014 Q1	$1.93M	Sell	54,177 -210,067	-79%	-$7.09M	﹤0.01%	1192
2013 Q4	$8.55M	Buy	+264,244	New	+$7.84M	0.01%	837

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Advisors's ISEE Position: Q4 2016 in Review

BlackRock Advisors increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 219% in Q4 2016, buying an estimated $3.88M and bringing the position to 190,295 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

BlackRock Advisors first reported a position in ISEE in Q4 2013 and has held it in 13 quarters since. The position peaked at $8.55M in Q4 2013. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

BlackRock Advisors held 190,295 shares of IVERIC bio, Inc. Common Stock worth $919K as of Q4 2016.
BlackRock Advisors bought 130,731 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $3.88M.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1902 holding.
BlackRock Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
BlackRock Advisors's IVERIC bio, Inc. Common Stock position peaked at $8.55M in Q4 2013.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.